S
Sheila Scully
Researcher at Amgen
Publications - 44
Citations - 9395
Sheila Scully is an academic researcher from Amgen. The author has contributed to research in topics: Osteoclast & Osteoprotegerin. The author has an hindex of 32, co-authored 44 publications receiving 9041 citations. Previous affiliations of Sheila Scully include University of Tokyo.
Papers
More filters
Journal ArticleDOI
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
Hailing Hsu,David L. Lacey,Colin R. Dunstan,Irina Solovyev,Anne Colombero,Emma Timms,Hong-Lin Tan,Gary Elliott,Michael J. Kelley,Ildiko Sarosi,Ling Wang,Xing-Zhong Xia,Robin Elliott,Laura Chiu,Tabitha Black,Sheila Scully,Casey Capparelli,Sean Morony,Grant Shimamoto,Michael Bass,William J. Boyle +20 more
TL;DR: Data indicate that OPGL-induced osteoclastogenesis is directly mediated through RANK on osteocLast precursor cells, and polyclonal Ab against the RANK extracellular domain promotes osteoclineogenesis in bone marrow cultures suggesting that RANK activation mediates the effects of OPGl on the osteoc last pathway.
Journal ArticleDOI
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
Ji Li,Ildiko Sarosi,Xiao-Qiang Yan,Sean Morony,Casey Capparelli,Hong-Lin Tan,Susan McCabe,Robin Elliott,Sheila Scully,Gwyneth Van,Stephen J. Kaufman,Shao-Chieh Juan,Yu Sun,John E. Tarpley,Laura Martín,Kathleen Christensen,James McCabe,Paul J. Kostenuik,Hailing Hsu,Frederick A. Fletcher,Colin R. Dunstan,David L. Lacey,William J. Boyle +22 more
TL;DR: Data indicate that RANK is the intrinsic cell surface determinant that mediates osteoprotegerin ligand effects on bone resorption and remodeling as well as the physiological and pathological effects of calciotropic hormones and proresorptive cytokines.
Journal ArticleDOI
T-cell co-stimulation through B7RP-1 and ICOS
Steven Kiyoshi Yoshinaga,John Whoriskey,Sanjay D. Khare,Ulla Sarmiento,Jane Guo,Tom Horan,Grace Shih,Ming Zhang,Marco A. Coccia,Tadahiko Kohno,Anna Tafuri-Bladt,David W. Brankow,Pauline Campbell,David Chang,Laura Chiu,Tianang Dai,Gordon S. Duncan,Gary Elliott,Ariela Hui,Susan McCabe,Sheila Scully,Arda Shahinian,Christine L. Shaklee,Gwyneth Van,Tak W. Mak,Giorgio Senaldi +25 more
TL;DR: A new murine co-stimulatory receptor–ligand pair is described that is structurally related to CD28–B7 and is involved in the adaptive immune response and defined as B7RP-1, which exhibits co- Stimulation activities in vitro and in vivo.
Journal ArticleDOI
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
Jimmie E. Fata,Young-Yun Kong,Young-Yun Kong,Ji Li,Takehiko Sasaki,Junko Irie-Sasaki,Roger A. Moorehead,Robin Elliott,Sheila Scully,Evelyn B. Voura,David L. Lacey,William J. Boyle,Rama Khokha,Josef M. Penninger +13 more
TL;DR: It is reported that mice lacking OPGL or its receptor RANK fail to form lobulo-alveolar mammary structures during pregnancy, resulting in death of newborns and a novel paradigm in mammary gland development and an evolutionary rationale for hormonal regulation and gender bias of osteoporosis in females.
Journal ArticleDOI
Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis
Hosung Min,Sean Morony,Ildiko Sarosi,Colin R. Dunstan,Casey Capparelli,Sheila Scully,Gwyneth Van,Steve Kaufman,Paul J. Kostenuik,David L. Lacey,William J. Boyle,W. Scott Simonet +11 more
TL;DR: Findings indicate that the OPG/OPGL/RANK signaling pathway may play an important role in both pathological and physiological calcification processes and may also explain the observed high clinical incidence of vascular calcification in the osteoporotic patient population.